Literature DB >> 24791831

The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients.

Wilfried De Backer1, Wim Vos2, Cedric Van Holsbeke2, Samir Vinchurkar2, Rita Claes1, Annemie Hufkens1, Paul M Parizel3, Lieven Bedert4, Jan De Backer5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24791831     DOI： 10.1183/09031936.00011714

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  16 in total

Review 1.  In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors:  Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

2.  Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products.

Authors:  Leslie Hendeles; Peter T Daley-Yates; Robert Hermann; Jan De Backer; Sanjeeva Dissanayake; Stephen T Horhota
Journal:  AAPS J       Date:  2015-02-26       Impact factor: 4.009

Review 3.  Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.

Authors:  Jimmy Chong; Bonnie Leung; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2017-09-19

Review 4.  Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold?

Authors:  Maria Gabriella Matera; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2014-11       Impact factor: 9.546

5.  Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.

Authors:  Sadia Janjua; Rebecca Fortescue; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

6.  Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA.

Authors:  Wim Vos; Bita Hajian; Jan De Backer; Cedric Van Holsbeke; Samir Vinchurkar; Rita Claes; Annemie Hufkens; Paul M Parizel; Lieven Bedert; Wilfried De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-02-04

7.  Pathophysiological mechanism of long-term noninvasive ventilation in stable hypercapnic patients with COPD using functional respiratory imaging.

Authors:  Bita Hajian; Jan De Backer; Claire Sneyers; Francisca Ferreira; Katherine C Barboza; Glenn Leemans; Wim Vos; Wilfried De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-28

8.  Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD).

Authors:  Angela T Burge; Narelle S Cox; Michael J Abramson; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2020-04-16

9.  Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.

Authors:  Bita Hajian; Jan De Backer; Wim Vos; Cedric Van Holsbeke; Francisca Ferreira; Deborah A Quinn; Annemie Hufkens; Rita Claes; Wilfried De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-05

10.  Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.

Authors:  Gunnar Johansson; Vasili Mushnikov; Tobias Bäckström; Andreas Engström; Javaria Mona Khalid; Jennifer Wall; Fabian Hoti
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.